Skip to main content
ASRT
NASDAQ Life Sciences

Assertio 将 Sympazan® 和其他产品出售给 Cosette Pharma

feedReported by Reuters
Sentiment info
Neutral
Importance info
8
Price
$18.15
Mkt Cap
$118.655M
52W Low
$7.706
52W High
$20.45
Market data snapshot near publication time

summarizeSummary

Assertio Holdings, Inc. 已宣布将其 Sympazan® 产品和其他产品出售给 Cosette Pharmaceuticals。这笔交易具有重要意义，因为它发生在 Assertio 同意被 Garda Therapeutics 收购之后不久，之前曾报道过这一重大事件。这些资产的出售改变了 Assertio 的产品组合，这对于一家正在经历全盘收购的公司至关重要，可能会影响 Garda 交易的最终估值或条款。交易者将密切关注这一出售的财务细节以及对待定的收购的任何进一步影响。

在该公告发布时，ASRT的交易价格为$18.15，交易所为NASDAQ，所属行业为Life Sciences，市值约为$1.2亿。 52周交易区间为$7.71至$20.45。 这则新闻被评估为中性市场情绪，重要性评分为8/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed ASRT - Latest Insights

ASRT
Apr 21, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Announces April 29 Tender Offer Commencement for Garda Therapeutics Acquisition
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 14, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Completes $35M Product Divestiture to Cosette Pharma, Bolstering Cash Ahead of Acquisition
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 09, 2026, 8:09 AM EDT
Filing Type: SC TO-C
Importance Score:
9
Assertio Holdings Files Tender Offer Communication for $18/Share Cash Acquisition by Garda Therapeutics, Plus CVR
Sentiment: Positive
View Wiseek Article
ASRT
Apr 09, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
10
Assertio to be Acquired by Garda Therapeutics for $18/Share Cash Plus CVR; Divests Non-Rolvedon Assets to Cosette for $35M Upfront
Sentiment: Positive
View Wiseek Article
ASRT
Apr 08, 2026, 5:10 PM EDT
Source: Reuters
Importance Score:
8
Assertio Divests Sympazan® and Other Products to Cosette Pharma
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 08, 2026, 4:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Assertio Agrees to Be Acquired by Garda Therapeutics
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 06, 2026, 5:26 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Shareholders to Vote on 6.2% Equity Plan Increase and Director Elections
Sentiment: Neutral
View Wiseek Article
ASRT
Mar 16, 2026, 5:07 PM EDT
Filing Type: 10-K
Importance Score:
8
Assertio Holdings Reports Increased Net Loss, Negative Cash Flow, and Details Reverse Stock Split
Sentiment: Negative
View Wiseek Article
ASRT
Mar 16, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Reports Q4 Loss, Projects Significant FY2026 Adjusted EBITDA Growth
Sentiment: Neutral
View Wiseek Article
ASRT
Mar 13, 2026, 4:11 PM EDT
Source: Reuters
Importance Score:
7
Significant Loss of $2.71/Share, 48.3% Revenue Drop Expected for Assertio Holdings
Sentiment: Negative
View Wiseek Article